Clinical Trial Update: Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nivolumab with chemoradiation for stage II-IVB nasopharyngeal carcinoma completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Sue Yom | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2026-01-12